Aspiriant LLC
FNDF icon

Aspiriant LLC’s Schwab Fundamental International Large Company Index ETF FNDF Stock Holding History

Aspiriant LLC’s Portfolio FNDF Stock Details FNDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$14.5M Sell
270,540
-4,961
-2% -$270K 0.36% 40
2026
Q2 		$14.5M Buy
275,501
+7,718
+3% +$406K 0.36% 40
2026
Q1 		$13.1M Buy
267,783
+10,380
+4% +$508K 0.37% 39
2025
Q4 		$11.6M Buy
257,403
+5,174
+2% +$229K 0.33% 41
2025
Q3 		$10.8M Buy
252,229
+4,131
+2% +$172K 0.33% 40
2025
Q2 		$9.9M Buy
248,098
+11,865
+5% +$447K 0.32% 40
2025
Q1 		$8.54M Buy
236,233
+15,022
+7% +$530K 0.3% 41
2024
Q4 		$7.35M Buy
221,211
+22,021
+11% +$778K 0.27% 45
2024
Q3 		$7.44M Buy
199,190
+165
+0.1% +$5.94K 0.28% 43
2024
Q2 		$6.97M Buy
199,025
+2,978
+2% +$106K 0.28% 46
2024
Q1 		$6.98M Buy
196,047
+2,680
+1% +$91K 0.29% 47
2023
Q4 		$6.52M Buy
193,367
+9,495
+5% +$304K 0.29% 47
2023
Q3 		$5.82M Buy
183,872
+1,783
+1% +$57.8K 0.3% 47
2023
Q2 		$5.88M Buy
182,089
+12,218
+7% +$391K 0.3% 46
2023
Q1 		$5.31M Buy
169,871
+2,549
+2% +$78.9K 0.28% 49
2022
Q4 		$4.86M Buy
167,322
+15,475
+10% +$435K 0.25% 51
2022
Q3 		$3.82M Buy
151,847
+5,833
+4% +$163K 0.19% 56
2022
Q2 		$4.14M Buy
146,014
+13,163
+10% +$403K 0.2% 58
2022
Q1 		$4.28M Buy
132,851
+15,459
+13% +$504K 0.24% 55
2021
Q4 		$3.82M Buy
117,392
+69,926
+147% +$2.31M 0.2% 58
2021
Q3 		$1.56M Buy
47,466
+7,524
+19% +$249K 0.09% 86
2021
Q2 		$1.33M Buy
39,942
+22,382
+127% +$752K 0.08% 96
2021
Q1 		$565K Sell
17,560
-47,269
-73% -$1.48M 0.04% 138
2020
Q4 		$1.9M Buy
64,829
+26,927
+71% +$729K 0.13% 71
2020
Q3 		$931K Buy
37,902
+16,741
+79% +$416K 0.07% 100
2020
Q2 		$503K Sell
21,161
-17,141
-45% -$387K 0.05% 128
2020
Q1 		$806K Buy
+38,302
New +$990K 0.08% 91
2018
Q4 		– Sell
-11,615
Closed -$347K – 236
2018
Q3 		$347K Sell
11,615
-826
-7% -$24.5K 0.03% 182
2018
Q2 		$368K Sell
12,441
-21,713
-64% -$660K 0.03% 183
2018
Q1 		$1.02M Buy
+34,154
New +$1.05M 0.09% 101

Other funds holding FNDF

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Regions Financial Corp
Regions Financial Corp Birmingham, Alabama $16.4B AUM 18.73% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Mountain Capital Investment Advisors
Mountain Capital Investment Advisors Westminster, Colorado $719M AUM 15.04% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Auto-Owners Insurance
Auto-Owners Insurance Lansing, Michigan $3.2B AUM 21.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Savant Capital
Savant Capital Rockford, Illinois $35B AUM 15.18% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return

Aspiriant LLC's FNDF Position: Q3 2026 in Review

Aspiriant LLC reduced its Schwab Fundamental International Large Company Index ETF (FNDF) stake by 1.8% in Q3 2026, selling an estimated $270K and leaving 270,540 shares worth $14.5M. The position accounts for 0.36% of the portfolio, ranked #40.

Aspiriant LLC first reported a position in FNDF in Q1 2018 and has held it in 30 quarters since. 650 funds tracked by Wall St. Rank hold FNDF as of Q3 2026.

  • Aspiriant LLC held 270,540 shares of Schwab Fundamental International Large Company Index ETF worth $14.5M as of Q3 2026.
  • Aspiriant LLC sold 4,961 Schwab Fundamental International Large Company Index ETF shares in Q3 2026, an estimated $270K.
  • Schwab Fundamental International Large Company Index ETF made up 0.36% of Aspiriant LLC's portfolio in Q3 2026, its #40 holding.
  • Aspiriant LLC first reported a position in Schwab Fundamental International Large Company Index ETF in Q1 2018 and has held it in 30 quarters since.
  • 650 funds tracked by Wall St. Rank held Schwab Fundamental International Large Company Index ETF as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.